Close Menu

NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Monday that its second quarter revenues increased 45 percent year over year.

For the three months ended June 30, the San Diego-based liquid biopsy firm saw $1.2 million in revenues compared to the $822,238 it brought in during the same quarter last year.

According to the company, revenue growth reflects a shift in commercial efforts toward specific segments of the oncology market where Biocept believes its assays can help the most patients: prostate, breast, and lung cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.